Remove Physicals Remove Provider Remove Specialization Remove Webinar
article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law Blog

While no “special registration” will yet be required to engage in telemedicine prescribing of controlled substances, DEA is proposing parameters to guide the practice of telemedicine encounters in a post-COVID world. a)(3), provided certain requirements, including requirements under state laws and conditions are met. 21 U.S.C. §

article thumbnail

Through Enforcement Discretion, FDA Facilitates Market Entry for New Infant Formulas (For Now); President Invokes Defense Production Act

FDA Law Blog

The guidance offers an opportunity that could be of special interest to foreign manufacturers who already market infant formula in other countries and have considered entering the U.S. FDA announced a webinar to be held on May 20 th that will provide an overview of the guidance and give manufacturers an opportunity to ask questions.

article thumbnail

Hospital-at-Home: Bruce Leff and Tacara Soones

GeriPal

And we would provide ongoing longitudinal care to them in the home, much like the Mount Sinai Visiting Doctors programs, and other programs like that. And the treatments are different than what hospice might provide in the home setting. And some things are, actually, more expensive to provide in the home, right? Tacara: Exactly.

Hospital 115